Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Santoni-Rugiu

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Anticancer Research|October 28, 2015
Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural MesotheliomaMorten Andersen, Davide Trapani, Jesper Ravn, et al.
International Journal of Molecular Sciences|July 12, 2025
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced <i>ALK</i>-Rearranged NSCLCEdyta Maria Urbanska, Peter Rindom Koffeldt, Morten Grauslund, et al.
Ugeskrift for Laeger|January 5, 2013
[Lack of uniformity in the treatment of thymomas]Julie Abildgaard, Helle Pappot, Peter Meidahl Petersen, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2012
A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesotheliomaZarah Glad Zimling, Jens Benn Sørensen, Thomas Alexander Gerds, et al.
Ugeskrift for Laeger|January 14, 2020
[Management of thymomas and thymic carcinomas]Peter Meidahl Petersen, Anna Kalhauge, Bodil Brandt, et al.
International Journal of Cancer|September 9, 2011
Urokinase plasminogen activator receptor on invasive cancer cells: a prognostic factor in distal gastric adenocarcinomaWarner Alpízar-Alpízar, Ib Jarle Christensen, Eric Santoni-Rugiu, et al.
The American Journal of Pathology|March 25, 2004
Transit-amplifying ductular (oval) cells and their hepatocytic progeny are characterized by a novel and distinctive expression of delta-like protein/preadipocyte factor 1/fetal antigen 1Charlotte Harken Jensen, Eva Irene Jauho, Eric Santoni-Rugiu, et al.
Hepatology (Baltimore, Md.)|June 1, 2007
Remarkable heterogeneity displayed by oval cells in rat and mouse models of stem cell-mediated liver regenerationPeter Jelnes, Eric Santoni-Rugiu, Morten Rasmussen, et al.
International Journal of Molecular Sciences|December 10, 2021
Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant MesotheliomaEric Santoni-Rugiu, Maya Jeje Schuang Lü, Jan Nyrop Jakobsen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 14, 2012
Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?Morten Andersen, Morten Grauslund, Marwa Muhammad-Ali, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Anticancer Research|October 28, 2015
Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural MesotheliomaMorten Andersen, Davide Trapani, Jesper Ravn, et al.
International Journal of Molecular Sciences|July 12, 2025
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced <i>ALK</i>-Rearranged NSCLCEdyta Maria Urbanska, Peter Rindom Koffeldt, Morten Grauslund, et al.
Ugeskrift for Laeger|January 5, 2013
[Lack of uniformity in the treatment of thymomas]Julie Abildgaard, Helle Pappot, Peter Meidahl Petersen, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2012
A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesotheliomaZarah Glad Zimling, Jens Benn Sørensen, Thomas Alexander Gerds, et al.
Ugeskrift for Laeger|January 14, 2020
[Management of thymomas and thymic carcinomas]Peter Meidahl Petersen, Anna Kalhauge, Bodil Brandt, et al.
International Journal of Cancer|September 9, 2011
Urokinase plasminogen activator receptor on invasive cancer cells: a prognostic factor in distal gastric adenocarcinomaWarner Alpízar-Alpízar, Ib Jarle Christensen, Eric Santoni-Rugiu, et al.
The American Journal of Pathology|March 25, 2004
Transit-amplifying ductular (oval) cells and their hepatocytic progeny are characterized by a novel and distinctive expression of delta-like protein/preadipocyte factor 1/fetal antigen 1Charlotte Harken Jensen, Eva Irene Jauho, Eric Santoni-Rugiu, et al.
Hepatology (Baltimore, Md.)|June 1, 2007
Remarkable heterogeneity displayed by oval cells in rat and mouse models of stem cell-mediated liver regenerationPeter Jelnes, Eric Santoni-Rugiu, Morten Rasmussen, et al.
International Journal of Molecular Sciences|December 10, 2021
Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant MesotheliomaEric Santoni-Rugiu, Maya Jeje Schuang Lü, Jan Nyrop Jakobsen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 14, 2012
Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?Morten Andersen, Morten Grauslund, Marwa Muhammad-Ali, et al.
Pageof 10